Disease | leukemia, acute myeloid |
Comorbidity | C0019829|hodgkin lymphoma |
Sentences | 1 |
PubMedID- 22708037 | The risk of therapy-related myelodysplasia/acute myeloid leukemia in hodgkin lymphoma has substantially decreased in the abvd era abolishing mechlorethamine and procarbazine and limiting volumes and doses of radiotherapy. |
Page: 1